{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-139580","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2024-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.071932+00:00","generated_at":"2026-05-28T23:38:22.495399+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Mahendra Shah resigns from Bolt Biotherapeutics board; Dupont added to two committees","bullets":["Dr. Mahendra Shah notified his resignation on Dec 19, effective Dec 31, 2024, for personal reasons.","Shah's departure not due to any disagreement with the company's operations, policies, or practices.","Board appointed existing director Dr. Jakob Dupont to the Audit Committee and Nominating and Corporate Governance Committee, effective upon Shah's resignation."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-139580","json":"https://secwatch.observer/filing/0000950170-24-139580.json","markdown":"https://secwatch.observer/filing/0000950170-24-139580.md","text":"https://secwatch.observer/filing/0000950170-24-139580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/0000950170-24-139580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/bolt-20241223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:38:22.495399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}